Piceatannol Prevents Colon Cancer Progression via Dual-Targeting to M2-Polarized Tumor-Associated Macrophages and the TGF-β1 Positive Feedback Signaling Pathway.
Yi-Shiou ChiouYi-Ming LanPei-Sheng LeeQianyu LinNagabhushanam KalyanamChi-Tang HoMin-Hsiung PanPublished in: Molecular nutrition & food research (2022)
These novel findings demonstrate that PIC is a potent TGF-β1/TGF-βR1 pathway inhibitor and TME modulator for preventing tumor progression and metastasis in CRC by reeducating TAMs.